4//SEC Filing
Wells David R. 4
Accession 0001209191-19-030069
CIK 0001681682other
Filed
May 14, 8:00 PM ET
Accepted
May 15, 5:00 PM ET
Size
5.4 KB
Accession
0001209191-19-030069
Insider Transaction Report
Form 4
Wells David R.
Chief Financial Officer
Transactions
- Award
Stock Options
2019-05-13+56,000→ 56,000 totalExercise: $1.38Exp: 2029-05-13→ Common Stock (56,000 underlying)
Footnotes (1)
- [F1]These Stock Options become exercisable in three equal annual installments beginning on May 13, 2020.
Documents
Issuer
ENDRA Life Sciences Inc.
CIK 0001681682
Entity typeother
Related Parties
1- filerCIK 0001480371
Filing Metadata
- Form type
- 4
- Filed
- May 14, 8:00 PM ET
- Accepted
- May 15, 5:00 PM ET
- Size
- 5.4 KB